Treace Medical Concepts, Inc.TMCI
Price (close)
$4.54
Market cap
$295.3M
P/E
—
Revenue (TTM)
$205.3M
Net income
-$59.5M
Dividend yield
—
1-year total return
-32.0%
Net margin
-29.0%
Revenue growth
-4.0%
Debt / equity
0.87x
What Treace Medical Concepts, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $57.4M | $94.4M | $141.8M | $187.1M | $209.4M | $212.7M |
| Net income | -$3.7M | -$20.6M | -$42.8M | -$49.5M | -$55.7M | -$59.0M |
| Free cash flow | -$5.6M | -$19.9M | -$45.5M | -$46.0M | -$48.8M | -$29.5M |
More on TMCI.
- Treace Medical Concepts, Inc. summary
- Treace Medical Concepts, Inc. financial statements
- Treace Medical Concepts, Inc. key metrics
- Treace Medical Concepts, Inc. health scores and style box
- Treace Medical Concepts, Inc. earnings
- Treace Medical Concepts, Inc. dividends
- Treace Medical Concepts, Inc. valuation
- Treace Medical Concepts, Inc. ownership and insiders
- Treace Medical Concepts, Inc. peers
Figures from Treace Medical Concepts, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.